XNCR Xencor Inc
Company Analysis
Latest News
🔴 Xencor is trading 5% down amid biotech-sector weakness
Xencor is trading at $24.50, down 5.21%, alongside weakness across biotech stocks. - XBI is down 2.08% during the session, while broader markets are also...
Xencor's Kidney Cancer Drug Gets Its Biggest Test Yet — Can Early Data Justify a Stock That Has Already Doubled?
Shares surged +8.4% to $28.00 as Xencor's most important clinical catalyst arrived: early-stage trial results for its experimental kidney cancer drug, a...
🟢 Xencor is trading 8.4% up in pre-market ahead of scheduled XmAb819 Phase 1 results
Xencor is trading at $28.00, up 8.36%, ahead of scheduled XmAb819 Phase 1 updates, though available coverage does not directly link the pre-market move to...
🟢 Xencor is trading 6.3% up in pre-market amid a 3.64% biotech-sector gain
Xencor is trading 6.26% higher at $26.50 before the October 21, 2026 market open, amid a reported 3.64% pre-market gain in the biotech sector. - Shares closed...
🟢 Xencor is trading 5.3% up today amid a biotech-sector rally
Xencor is trading at $24.42, up +5.30%, with broader biotech strength as context; no clear Xencor-specific announcement explains today’s move. - XBI is up...